Search
Menu
Sheetak -  Cooling at your Fingertip 11/24 LB

LaserSight Gets FDA Approval for 200-Hz Performance

Facebook X LinkedIn Email
WINTER PARK, Fla., Nov. 2 -- LaserSight Inc. said its PMA supplement to increase the repetition rate of its LaserScan LSX microspot scanning system to 200 Hz for the LASIK treatment of myopia and myopic astigmatism was approved by the FDA. The PMA supplement was submitted to the FDA on Oct. 5 with a request for review on a 30-day real-time basis. This approval is necessary for the launch of the LaserScan LSX, which is the only laser system approved in the US that combines a 200-Hz repetition rate, a microspot and the high resolution of optimized low-laser fluence.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: November 2001
    News & FeaturesLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.